Effects of different statin types and dosages on systolic/diastolic blood pressure: Retrospective analysis of 24-hour ambulatory blood pressure database
- PMID: 29683251
- PMCID: PMC8030899
- DOI: 10.1111/jch.13283
Effects of different statin types and dosages on systolic/diastolic blood pressure: Retrospective analysis of 24-hour ambulatory blood pressure database
Abstract
We previously demonstrated lower diastolic blood pressure (BP) levels under statin therapy in adult individuals who consecutively underwent 24-hour ambulatory BP monitoring and compared their levels to untreated outpatients. Here we evaluated systolic/diastolic BP levels according to different statin types and dosages. 987 patients (47.5% female, age 66.0 ± 10.1 years, BMI 27.7 ± 4.6 kg/m2 , clinic BP 146.9 ± 19.4/86.1 ± 12.1 mm Hg, 24-hour BP 129.2 ± 14.4/74.9 ± 9.2 mm Hg) were stratified into 4 groups: 291 (29.5%) on simvastatin 10-80 mg/d, 341 (34.5%) on atorvastatin 10-80 mg/d, 187 (18.9%) on rosuvastatin 5-40 mg/d, and 168 (17.0%) on other statins. There were no significant BP differences among patients treated by various statin types and dosages, except in lower clinic (P = .007) and daytime (P = .013) diastolic BP in patients treated with simvastatin and atorvastatin compared to other statins. Favorable effects of statins on systolic/diastolic BP levels seem to be independent of types or dosages, thus suggesting a potential class effect of these drugs.
Keywords: ambulatory blood pressure monitoring; hypertension; nighttime blood pressure; statins.
©2018 Wiley Periodicals, Inc.
Conflict of interest statement
Authors have no conflicts of interest to disclose on the contents of the present manuscript.
Figures


Similar articles
-
Favourable impact of statin use on diastolic blood pressure levels: analysis of a large database of 24-hour ambulatory blood pressure monitoring.J Hypertens. 2017 Oct;35(10):2086-2094. doi: 10.1097/HJH.0000000000001419. J Hypertens. 2017. PMID: 28582284
-
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.Vasc Health Risk Manag. 2013;9:719-27. doi: 10.2147/VHRM.S49840. Epub 2013 Nov 15. Vasc Health Risk Manag. 2013. PMID: 24265554 Free PMC article.
-
Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial.Arch Intern Med. 2008 Apr 14;168(7):721-7. doi: 10.1001/archinte.168.7.721. Arch Intern Med. 2008. PMID: 18413554 Free PMC article. Clinical Trial.
-
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis.Hypertension. 2016 Apr;67(4):693-700. doi: 10.1161/HYPERTENSIONAHA.115.06981. Epub 2016 Feb 22. Hypertension. 2016. PMID: 26902495 Review.
-
Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER.Eur Heart J Cardiovasc Pharmacother. 2016 Oct;2(4):212-7. doi: 10.1093/ehjcvp/pvw006. Epub 2016 Mar 29. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27533947 Review.
Cited by
-
Achievement of target blood pressure among community residents with hypertension and factors associated with therapeutic failure in the northern territory of Japan.J Int Med Res. 2022 Oct;50(10):3000605221126878. doi: 10.1177/03000605221126878. J Int Med Res. 2022. PMID: 36314244 Free PMC article.
-
Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network Registry.J Am Heart Assoc. 2022 Mar;11(5):e022345. doi: 10.1161/JAHA.121.022345. Epub 2022 Jan 19. J Am Heart Assoc. 2022. PMID: 35043688 Free PMC article.
-
Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin.J Lipid Atheroscler. 2020 May;9(2):283-290. doi: 10.12997/jla.2020.9.2.283. Epub 2020 Mar 6. J Lipid Atheroscler. 2020. PMID: 32821737 Free PMC article.
References
-
- Tocci G, Sciarretta S, Volpe M. Development of heart failure in recent hypertension trials. J Hypertens. 2008;26:1477‐1486. - PubMed
-
- Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta‐analysis. Lancet. 2016;387:957‐967. - PubMed
-
- O'Brien E, Parati G, Stergiou G, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731‐1768. - PubMed
-
- Parati G, Stergiou G, O'Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359‐1366. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical